Day One Biopharmaceuticals (DAWN) Stock Highlights

15.01 | -0.46%

2024-10-21 02:25:32

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Statistics

Range Today

14.77 15.28

Volume Today 530.4K

Range 1 Year

9.67 18.07

Volume 1 Year 222.85M

Range 3 Year

5.44 28.35

Volume 3 Year 597.57M

Range 10 Year

5.44 28.7

Volume 10 Year 611.29M

Highlights

Market Capitalization 1.48B (small)

Floating Shares 60.1M

Current Price 15.01

Price To Earnings -7.8

Price To Revenue 116.65

Price To Book 4.29

Earnings Per Share -1.94

Payout Ratio 0%

Performance

Latest -0.46%

1 Month +8.53%

3 Months -3.72%

6 Months +1.01%

1 Year +45.3%

3 Years -28.59%

5 Years -39.96%

10 Years -39.96%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.